Skip to main content
logo
NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.770
0.00 (0.00%)
At close: Jul 24, 2026, 4:00 PM EDT
1.833
+0.063 (3.54%)
After-hours: Jul 24, 2026, 7:34 PM EDT

NovaBridge Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.63-1.5513.85
Revenue Growth
------94.14%
Gross Profit
---0.63-1.5513.85
Operating Income
-94.27-94.27-51.43-72.02-53.08-325.89
Net Income
-46.27-46.27-22.23-207.73-371.05-366.83
Earnings Per Share
-0.48-0.48-0.28-2.51-4.51-4.83
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
210.84210.84173.4311.73500.07672.89
Total Debt
3.073.073.883.8910.8717.69
Net Cash (Debt)
207.78207.78169.52307.84489.2655.19
Net Cash Growth
22.57%22.57%-44.93%-37.07%-25.34%-10.39%
Net Cash Per Share
2.172.172.093.705.938.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.6-20.6-52.67-72.7-49.58-153.1
Capital Expenditures
-0.01-0.01-0.05-0.16-2.09-4.71
Free Cash Flow
-20.6-20.6-52.72-72.86-51.67-157.81
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----11395.10%3422.18%-2353.06%
Pretax Margin
----13009.02%9097.36%-2652.28%
Profit Margin
----13009.00%9104.00%-2655.86%
FCF Margin
----11528.60%3331.59%-1139.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-190.80190.80190.80190.80190.80
PS Ratio
---242.62-223.66273.49